FDA approves new antibiotic for uncomplicated urinary tract tnfections
Apr 30, 2024
Approval of Pivya is for female adults with UTIs caused by susceptible isolates of E. coli, P. mirabilis,and S. saprophyticus.
Use of CT angiogram on the rise for headache, dizziness in emergency department
Apr 17, 2024
There was a 67.4% increase in head and neck computed tomography angiography ordering for emergency department patients from 2017 to 2021.
FDA approves first prescription digital therapy for major depression
Apr 04, 2024
The adjunctive treatment, delivered via smartphone app, reduces depression symptoms in participants on antidepressant medication.
Few cancer survivors fully adherent to ACS nutrition and physical activity guidelines
Apr 23, 2024
Factors associated with greater adherence include female sex, older age, Black race and higher educational level.
FDA approves Rezdiffra for nonalcoholic steatohepatitis
Mar 15, 2024
Drug was approved on an ‘accelerated’ schedule due to pressing medical need
FDA approves Aurlumyn for severe frostbite
Feb 15, 2024
The newly approved medication lowers the need for amputation of fingers or toes.
FDA approves Wegovy to lower risk for CVD events in patients with obesity
Mar 08, 2024
Agency’s action could widen access to the drug if more insurance companies decide to cover it
Company seeks FDA approval for MDMA as treatment for PTSD
Dec 13, 2023
“If approved, MDMA-assisted therapy would be the first psychedelic-assisted therapy, which we hope will drive additional investment into new research in mental health.”
FDA approves new diet drug Zepbound, a version of the diabetes med Mounjaro
Nov 09, 2023
Zepbound works by activating hormone receptors in the body to reduce appetite and food intake
FDA approves new antibiotic for three indications
Apr 08, 2024
Zevtera is approved for S. aureus bloodstream infections, acute bacterial skin/skin structure infections and bacterial pneumonia.